关于终末期肝病模型（MELD）的概念发展：差值与临界值 - Suppr

Suppr

超能文献

Developing concepts on MELD: delta and cutoffs.

作者信息

D'Amico Gennaro

出版信息

J Hepatol. 2005 Jun;42(6):790-2. doi: 10.1016/j.jhep.2005.03.009. Epub 2005 Apr 7.

DOI:10.1016/j.jhep.2005.03.009

PMID:15885348

Abstract

摘要

相似文献

Developing concepts on MELD: delta and cutoffs.

J Hepatol. 2005 Jun;42(6):790-2. doi: 10.1016/j.jhep.2005.03.009. Epub 2005 Apr 7.

Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.

J Hepatol. 2005 Jun;42(6):826-32. doi: 10.1016/j.jhep.2005.01.019. Epub 2005 Mar 31.

Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.

Scand J Gastroenterol. 2009;44(3):346-57. doi: 10.1080/00365520802530838.

Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.

Liver Transpl. 2006 Jan;12(1):65-71. doi: 10.1002/lt.20560.

MELD: the answer or just more questions?

Gastroenterology. 2003 Jan;124(1):251-4. doi: 10.1053/gast.2003.50031.

Child, MELD, hyponatremia, and now portal pressure.

Gastroenterology. 2006 May;130(6):1920-1; discussion 1921-2. doi: 10.1053/j.gastro.2006.01.084.

Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era.

Hepatology. 2005 Oct;42(4):793-801. doi: 10.1002/hep.20871.

Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.

Liver Int. 2006 Feb;26(1):55-61. doi: 10.1111/j.1478-3231.2005.01190.x.

Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.

Am J Gastroenterol. 2009 May;104(5):1147-58. doi: 10.1038/ajg.2009.31. Epub 2009 Apr 7.

Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.

J Clin Gastroenterol. 2007 Aug;41(7):706-12. doi: 10.1097/MCG.0b013e31802dabb3.

引用本文的文献

Plasma fetal bile acids 7α-hydroxy-3-oxochol-4-en-24-oic acid and 3-oxachola-4,6-dien-24-oic acid indicate severity of liver cirrhosis.

Sci Rep. 2021 Apr 15;11(1):8298. doi: 10.1038/s41598-021-87921-5.

Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.

PLoS One. 2019 Oct 3;14(10):e0223053. doi: 10.1371/journal.pone.0223053. eCollection 2019.

Delta model for end-stage liver disease and delta clinical prognostic indicator as predictors of mortality in patients with viral acute liver failure.

Int J Crit Illn Inj Sci. 2017 Oct-Dec;7(4):252-255. doi: 10.4103/IJCIIS.IJCIIS_122_16.

Prognostic Value of Model for End-Stage Liver Disease Score Measurements on a Daily Basis in Critically Ill Patients With Cirrhosis.

Mayo Clin Proc. 2015 Sep;90(9):1196-206. doi: 10.1016/j.mayocp.2015.06.017. Epub 2015 Aug 3.

Model for end-stage liver disease: end of the first decade.

Clin Liver Dis. 2011 Nov;15(4):685-98. doi: 10.1016/j.cld.2011.08.009. Epub 2011 Oct 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验